China Geographic Atrophy Market (2025-2031) | Segmentation, Growth, Share, Value, Trends, Size & Revenue, Outlook, Industry, Analysis, Competitive Landscape, Companies, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Geographic Atrophy Market Revenues & Volume, 2021 & 2031F

3.3 China Geographic Atrophy Market - Industry Life Cycle

3.4 China Geographic Atrophy Market - Porter's Five Forces

3.5 China Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.6 China Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 China Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in China

4.2.2 Rising prevalence of age-related macular degeneration (AMD)

4.2.3 Technological advancements in diagnostic tools and treatment options

4.3 Market Restraints

4.3.1 Limited awareness about geographic atrophy and its treatment options

4.3.2 High cost associated with advanced treatment options

4.3.3 Stringent regulatory environment for new treatment approvals

6.1 China Geographic Atrophy Market, By Age Group

6.1.1 Overview and Analysis

6.1.2 China Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F

6.1.3 China Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F

6.1.4 China Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F

6.2 China Geographic Atrophy Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 China Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F

6.2.3 China Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F

6.2.4 China Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F

6.3 China Geographic Atrophy Market, By Therapeutic Agents Clinical Phase

6.3.1 Overview and Analysis

6.3.2 China Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F

6.3.3 China Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F

6.3.4 China Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F

7.1 China Geographic Atrophy Market Export to Major Countries

7.2 China Geographic Atrophy Market Imports from Major Countries

8.1 Number of patients diagnosed with geographic atrophy

8.2 Adoption rate of new diagnostic tools in ophthalmology clinics

8.3 Percentage of ophthalmologists trained in geographic atrophy treatment techniques

9.1 China Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.2 China Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 China Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F

10.1 China Geographic Atrophy Market Revenue Share, By Companies, 2024

10.2 China Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters